Predictors of Nonseroconversion after SARS-CoV-2 Infection.

TitlePredictors of Nonseroconversion after SARS-CoV-2 Infection.
Publication TypeJournal Article
Year of Publication2021
AuthorsLiu W, Russell RM, Bibollet-Ruche F, Skelly AN, Sherrill-Mix S, Freeman DA, Stoltz R, Lindemuth E, Lee F-H, Sterrett S, Bar KJ, Erdmann N, Gouma S, Hensley SE, Ketas T, Cupo A, Portillo VMCruz, Moore JP, Bieniasz PD, Hatziioannou T, Massey G, Minyard M-B, Saag MS, Davis RS, Shaw GM, Britt WJ, Leal SM, Goepfert P, Hahn BH
JournalEmerg Infect Dis
Volume27
Issue9
Pagination2454-2458
Date Published2021 Sep
ISSN1080-6059
KeywordsAntibody Formation, COVID-19, COVID-19 Serological Testing, Humans, Nasopharynx, SARS-CoV-2, Seroconversion
Abstract

Not all persons recovering from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection develop SARS-CoV-2-specific antibodies. We show that nonseroconversion is associated with younger age and higher reverse transcription PCR cycle threshold values and identify SARS-CoV-2 viral loads in the nasopharynx as a major correlate of the systemic antibody response.

DOI10.3201/eid2709.211042
Alternate JournalEmerg Infect Dis
PubMed ID34193339
PubMed Central IDPMC8386781
Grant ListR37 AI150590 / AI / NIAID NIH HHS / United States
T32 GM007170 / GM / NIGMS NIH HHS / United States
R01 AI110553 / AI / NIAID NIH HHS / United States
U19 AI082630 / AI / NIAID NIH HHS / United States
R01 AI050529 / AI / NIAID NIH HHS / United States
P01 AI110657 / AI / NIAID NIH HHS / United States
P30 AI045008 / AI / NIAID NIH HHS / United States
R01 AI036082 / AI / NIAID NIH HHS / United States

Weill Cornell Medicine Microbiology and Immunology 1300 York Avenue, Box 62 New York, NY 10065 Phone: (212) 746-6505 Fax: (212) 746-8587